NCT03370705View on ClinicalTrials.gov

Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone

PHASE3UnknownINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

March 30, 2020

Conditions
Peripheral Arterial Obstructive Disease
Interventions
DRUG

Sulodexide

Sulodexide 250 ULS twice daily per oral route

DRUG

Statin

Statin 20mg once daily per oral route,

DRUG

Antiplatelet Agents

Antiplatelet therapy 75mg once daily per oral route

DRUG

ACE inhibitor

ACE inhibitor 20mg once daily per oral route

Trial Locations (3)

1006

InvSite Poseidon0011, Tunis

3000

InvSite Poseidon0031, Sfax

4000

InvSite Poseidon 0022, Sousse

Sponsors

Collaborators (1)

Poseidon CRO
All Listed Sponsors
collaborator

Poseidon CRO

INDUSTRY

lead

Alfa Wassermann Tunisia

INDUSTRY